These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

28 related articles for article (PubMed ID: 15704064)

  • 1. Effect of hypoproteinemia on mortality of elderly male patients with chronic heart failure.
    Tan Y; Xiang W; Chen Y; Huang J; Sun D
    Medicine (Baltimore); 2024 Feb; 103(5):e37078. PubMed ID: 38306508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum brain natriuretic peptide levels may be a useful marker for early diagnosis of cardiomyopathy secondary to neuroblastoma: A case report.
    Fujiyama N; Matsuo O; Yamashita T; Kohrogi K; Miyamura F; Anan T; Nakamura K
    Clin Case Rep; 2024 May; 12(5):e8738. PubMed ID: 38681045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GLVC scoring system: a single-center model for predicting survival and hospitalization in patients with heart failure.
    Chuda-Wietczak A; Sakowicz A; Tycinska A; Bytyci I; Bielecka-Dabrowa A
    Ir J Med Sci; 2023 Dec; 192(6):2713-2726. PubMed ID: 37041427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular diameter and risk stratification for sudden cardiac death.
    Narayanan K; Reinier K; Teodorescu C; Uy-Evanado A; Aleong R; Chugh H; Nichols GA; Gunson K; London B; Jui J; Chugh SS
    J Am Heart Assoc; 2014 Sep; 3(5):e001193. PubMed ID: 25227407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do optimal prognostic thresholds in continuous physiological variables really exist? Analysis of origin of apparent thresholds, with systematic review for peak oxygen consumption, ejection fraction and BNP.
    Giannoni A; Baruah R; Leong T; Rehman MB; Pastormerlo LE; Harrell FE; Coats AJ; Francis DP
    PLoS One; 2014; 9(1):e81699. PubMed ID: 24475020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.
    Jan A; Murphy NF; O'Loughlin C; Ledwidge M; McDonald K
    Ir J Med Sci; 2011 Jun; 180(2):355-62. PubMed ID: 21369749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic heart failure in Japan: implications of the CHART studies.
    Shiba N; Shimokawa H
    Vasc Health Risk Manag; 2008; 4(1):103-13. PubMed ID: 18629369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory biomarkers are not predictive of intermediate-term risk of ventricular tachyarrhythmias in stable CHF patients.
    Konstantino Y; Kusniec J; Reshef T; David-Zadeh O; Mazur A; Strasberg B; Battler A; Haim M
    Clin Cardiol; 2007 Aug; 30(8):408-13. PubMed ID: 17680622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.
    Doust JA; Pietrzak E; Dobson A; Glasziou P
    BMJ; 2005 Mar; 330(7492):625. PubMed ID: 15774989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brain natriuretic Peptide. Diagnostic and prognostic value in chronic heart failure].
    Krüger S; Hoffmann R; Graf J; Janssens U; Hanrath P
    Med Klin (Munich); 2003 Oct; 98(10):562-7. PubMed ID: 14586510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure.
    Watanabe J; Shiba N; Shinozaki T; Koseki Y; Karibe A; Komaru T; Miura M; Fukuchi M; Fukahori K; Sakuma M; Kagaya Y; Shirato K
    J Card Fail; 2005 Feb; 11(1):50-5. PubMed ID: 15704064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure.
    Berger R; Huelsman M; Strecker K; Bojic A; Moser P; Stanek B; Pacher R
    Circulation; 2002 May; 105(20):2392-7. PubMed ID: 12021226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tissue Doppler right ventricular systolic and diastolic function indexes combined with plasma B-type natriuretic Peptide in patients with advanced heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Bistola V; Parissis JT; Paraskevaidis I; Panou F; Nikolaou M; Ikonomidis I; Flessas N; Filippatos G; Iliodromitis E; Kremastinos DT
    Am J Cardiol; 2010 Jan; 105(2):249-54. PubMed ID: 20102927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-b-type natriuretic peptide and left atrial function in patients with congestive heart failure and severely reduced ejection fraction.
    Prastaro M; Paolillo S; Savarese G; Dellegrottaglie S; Scala O; Ruggiero D; Gargiulo P; Marciano C; Parente A; Cecere M; Musella F; Chianese D; Scopacasa F; Perrone-Filardi P
    Eur J Echocardiogr; 2011 Jul; 12(7):506-13. PubMed ID: 21685193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac natriuretic peptides for diagnosis and risk stratification in heart failure: influences of left ventricular dysfunction and coronary artery disease on cardiac hormonal activation.
    Selvais PL; Donckier JE; Robert A; Laloux O; van Linden F; Ahn S; Ketelslegers JM; Rousseau MF
    Eur J Clin Invest; 1998 Aug; 28(8):636-42. PubMed ID: 9767358
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.